ZA200004260B - Treatment of skin disorders. - Google Patents
Treatment of skin disorders.Info
- Publication number
- ZA200004260B ZA200004260B ZA200004260A ZA200004260A ZA200004260B ZA 200004260 B ZA200004260 B ZA 200004260B ZA 200004260 A ZA200004260 A ZA 200004260A ZA 200004260 A ZA200004260 A ZA 200004260A ZA 200004260 B ZA200004260 B ZA 200004260B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- skin disorders
- skin
- piperine
- analogues
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9815177.2A GB9815177D0 (en) | 1998-07-13 | 1998-07-13 | Treatment of skin disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200004260B true ZA200004260B (en) | 2001-07-25 |
Family
ID=10835429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200004260A ZA200004260B (en) | 1998-07-13 | 2000-08-18 | Treatment of skin disorders. |
Country Status (14)
Country | Link |
---|---|
US (1) | US6346539B1 (fr) |
EP (1) | EP1094813B1 (fr) |
JP (1) | JP2002520275A (fr) |
KR (1) | KR20010071872A (fr) |
CN (1) | CN1210029C (fr) |
AT (1) | ATE249220T1 (fr) |
AU (1) | AU757053B2 (fr) |
CA (2) | CA2735844C (fr) |
DE (1) | DE69911210T2 (fr) |
ES (1) | ES2207252T3 (fr) |
GB (1) | GB9815177D0 (fr) |
HK (1) | HK1033264A1 (fr) |
WO (1) | WO2000002544A2 (fr) |
ZA (1) | ZA200004260B (fr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9815177D0 (en) | 1998-07-13 | 1998-09-09 | King S College London | Treatment of skin disorders |
GB2370989A (en) * | 2001-01-16 | 2002-07-17 | Btg Int Ltd | Piperine analogues for the treatment of skin conditions |
US6680391B2 (en) | 1998-07-13 | 2004-01-20 | Btg International Limited | Treatment of skin conditions |
AU2001278849A1 (en) * | 2000-05-19 | 2001-12-03 | Sabinsa Corporation | Method of increased bioavailability of nutrients and pharmaceutical preparationswith tetrahydropiperine and its analogues and derivatives |
US7057040B2 (en) * | 2002-02-07 | 2006-06-06 | Council Of Scientific And Industrial Research | Substituted aryl alkenoic acid heterocyclic amides |
CN1389462A (zh) * | 2002-07-12 | 2003-01-08 | 复旦大学 | 大叶蒟素及其同系物,和在制备药物组合物中的应用 |
BRPI0411856A (pt) * | 2003-06-23 | 2006-08-29 | Geron Corp | composições e métodos para o aumento da atividade de telomerase |
WO2005000248A2 (fr) * | 2003-06-25 | 2005-01-06 | Geron Corporation | Compositions et procedes de traitement de la peau |
WO2005044179A2 (fr) * | 2003-06-27 | 2005-05-19 | Hong Kong University Of Science And Technology | Preparations contenant des extraits d'astragale et utilisations de celles-ci |
DE10335725A1 (de) * | 2003-08-05 | 2005-03-03 | Bayer Cropscience Gmbh | Safener auf Basis aromatisch-aliphatischer Carbonsäuredarivate |
JP4579564B2 (ja) * | 2004-03-16 | 2010-11-10 | 花王株式会社 | シワ改善剤 |
GB0600134D0 (en) * | 2006-01-05 | 2006-02-15 | Vernique Biotech Ltd | Use of epoxidised molecules |
KR100846125B1 (ko) | 2007-03-30 | 2008-07-15 | 바이오스펙트럼 주식회사 | 피페린을 유효성분으로 포함하는 피부주름 개선용 조성물 |
EP2011495A1 (fr) * | 2007-07-03 | 2009-01-07 | Sygnis Bioscience GmbH & Co. KG | Utilisation de pipérine et dérivés correspondants pour la thérapie de conditions neurologiques |
CH698627B1 (de) | 2007-08-16 | 2009-09-15 | Alpinia Laudanum Inst Of Phytopharmaceutical | Herstellung und Verwendung von Extrakten oder Extraktivstoffen aus Piper cubeba L. als wirksame Bestandteile in einem Medikament zur Behandlung von Krebserkrankungen. |
US20100222275A1 (en) * | 2007-10-19 | 2010-09-02 | Kunihiko Tamaki | Therapeutic agent for vitiligo and method of accelerating pigmentation |
CA2718400A1 (fr) * | 2008-03-11 | 2009-09-17 | The General Hospital Corporation | Piperlongumine et analogues de piperlongumine pour une utilisation dans le traitement du cancer |
KR101035956B1 (ko) * | 2008-09-05 | 2011-05-23 | 인하대학교 산학협력단 | 밀통화 추출물을 유효성분으로 함유하는 아토피성 피부 개선용 화장료 조성물 |
WO2010039681A1 (fr) * | 2008-09-30 | 2010-04-08 | Trustees Of The University Of Pennsylvania | Compositions et procédés pour traiter le vitiligo |
IL196695A (en) | 2009-01-25 | 2015-10-29 | Secret Of Youth Ltd | Preparations containing fruit and vegetable derivatives and their uses |
CN102448308B (zh) * | 2009-05-18 | 2014-08-06 | 吉隆公司 | 用于增加端粒酶活性的组合物和方法 |
JP5813436B2 (ja) * | 2011-09-22 | 2015-11-17 | 日本メナード化粧品株式会社 | 色素脱失の予防又は改善剤のスクリーニング法とそのスクリーニング法によって見出された色素脱失の予防又は改善剤 |
KR101186500B1 (ko) | 2012-01-31 | 2012-09-27 | 연세대학교 산학협력단 | 신규한 피페린 유도체 및 그의 용도 |
US9943563B2 (en) * | 2013-12-02 | 2018-04-17 | Stealth Biotherapeutics Corp | Compositions and methods for treating vitiligo |
CN104297225B (zh) * | 2014-09-29 | 2018-02-16 | 无限极(中国)有限公司 | 一种细胞内黑色素的快速检测与成像的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06336417A (ja) | 1993-03-31 | 1994-12-06 | Shiseido Co Ltd | 紫外線吸収剤及びそれを配合した皮膚外用剤 |
US5439891A (en) | 1993-10-29 | 1995-08-08 | Kapil; Randhir S. | Process for preparation of pharmaceutical composition with enhanced activity for treatment of tuberculosis and leprosy |
US5744161A (en) * | 1995-02-24 | 1998-04-28 | Sabinsa Corporation | Use of piperine as a bioavailability enhancer |
GB9815177D0 (en) | 1998-07-13 | 1998-09-09 | King S College London | Treatment of skin disorders |
-
1998
- 1998-07-13 GB GBGB9815177.2A patent/GB9815177D0/en not_active Ceased
-
1999
- 1999-07-13 ES ES99933032T patent/ES2207252T3/es not_active Expired - Lifetime
- 1999-07-13 DE DE69911210T patent/DE69911210T2/de not_active Expired - Lifetime
- 1999-07-13 CA CA2735844A patent/CA2735844C/fr not_active Expired - Fee Related
- 1999-07-13 EP EP99933032A patent/EP1094813B1/fr not_active Expired - Lifetime
- 1999-07-13 CN CNB998108391A patent/CN1210029C/zh not_active Expired - Fee Related
- 1999-07-13 KR KR1020017000515A patent/KR20010071872A/ko not_active Application Discontinuation
- 1999-07-13 WO PCT/GB1999/002256 patent/WO2000002544A2/fr not_active Application Discontinuation
- 1999-07-13 AU AU49209/99A patent/AU757053B2/en not_active Ceased
- 1999-07-13 JP JP2000558804A patent/JP2002520275A/ja not_active Withdrawn
- 1999-07-13 CA CA2337205A patent/CA2337205C/fr not_active Expired - Fee Related
- 1999-07-13 AT AT99933032T patent/ATE249220T1/de not_active IP Right Cessation
-
2000
- 2000-08-18 ZA ZA200004260A patent/ZA200004260B/xx unknown
-
2001
- 2001-01-16 US US09/759,137 patent/US6346539B1/en not_active Expired - Lifetime
- 2001-05-23 HK HK01103582A patent/HK1033264A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2337205A1 (fr) | 2000-01-20 |
HK1033264A1 (en) | 2001-08-24 |
JP2002520275A (ja) | 2002-07-09 |
US6346539B1 (en) | 2002-02-12 |
KR20010071872A (ko) | 2001-07-31 |
ATE249220T1 (de) | 2003-09-15 |
DE69911210T2 (de) | 2004-07-01 |
CN1330545A (zh) | 2002-01-09 |
AU757053B2 (en) | 2003-01-30 |
CA2735844C (fr) | 2013-10-01 |
ES2207252T3 (es) | 2004-05-16 |
GB9815177D0 (en) | 1998-09-09 |
WO2000002544A3 (fr) | 2000-05-04 |
CA2337205C (fr) | 2011-06-14 |
EP1094813A2 (fr) | 2001-05-02 |
EP1094813B1 (fr) | 2003-09-10 |
CN1210029C (zh) | 2005-07-13 |
WO2000002544A2 (fr) | 2000-01-20 |
DE69911210D1 (de) | 2003-10-16 |
AU4920999A (en) | 2000-02-01 |
CA2735844A1 (fr) | 2000-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9815177D0 (en) | Treatment of skin disorders | |
AU2207000A (en) | Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia | |
CA2301032A1 (fr) | Procede de prevention et traitement de maladies et troubles induits par oestrogenes | |
DK1373215T3 (da) | Gelanamycinderivater egnet til behandling af cancer | |
WO2001023405A3 (fr) | Traitement therapeutique d'affections causees par le recepteur androgene | |
MXPA00007388A (es) | Metodos para tratar la pigmentacion de la piel. | |
GB9903762D0 (en) | Organic compounds | |
SG169224A1 (en) | Method for treatment of tumors using nordihydrogualaretic acid derivatives | |
AP2002002596A0 (en) | Piperazine and piperidine derivatives. | |
ATE258796T1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
AU2838101A (en) | Use of melatonin for treating androgenetic and diffuse alopecia | |
EP0751778A4 (fr) | Preparations hygieniques et cosmetiques pour la prevention et le traitement des dermatoses, et leur procede d'obtention | |
MY137435A (en) | Retinoid compounds (i) | |
ATE271873T1 (de) | Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz | |
GB0215526D0 (en) | Anticancer compounds | |
MY120530A (en) | Combination preparation for use in dementia | |
PL376149A1 (en) | Piperazine and piperidine derivatives for treatment of neurological diseases | |
YU22802A (sh) | Izonipekotamidi za lečenje poremećaja nastalih posredstvom integrina | |
HK1082727A1 (en) | 2" oxo-voruscharin and derivatives thereof | |
DE69907685D1 (de) | Verwendung von derivaten von tetrahydropyridinen oder (4-hydroxypiperidin)-butylazolen zur herstellung von präparaten zur schmerzbehandlung | |
UA49674A (uk) | Спосіб комплексного лікування генералізованих форм злоякісної меланоми шкіри | |
UA64813C2 (uk) | Інтраназальний антисептик | |
UA49216A (uk) | Засіб для лікування ускладнень після видалення злоякісних новоутворень шкіри | |
UA32241A (uk) | Спосіб лікування запалювальних процесів у експериментальних тварин | |
MX9405923A (es) | Mejoras en proceso para humectar y suavizar la piel. |